Evidence Level
Moderate
Phosphatidylserine has a solid evidence base for cognitive support in aging populations. The FDA issued a qualified health claim in 2003 acknowledging that PS may reduce the risk of cognitive dysfunction in the elderly. Kato-Kataoka et al. (2010) demonstrated memory improvements in a 6-month RCT. Earlier bovine-derived PS studies (Crook et al., 1991) showed significant cognitive benefits, and soy-derived PS has been confirmed to have comparable efficacy. Monteleone et al. (1992) established the cortisol-blunting effect that makes PS valuable for stress management.